home / stock / wxxwy / wxxwy quote
Last: | $2.875 |
---|---|
Change Percent: | 1.53% |
Open: | $2.78 |
Close: | $2.875 |
High: | $2.88 |
Low: | $2.78 |
Volume: | 41,534 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.875 | $2.78 | $2.875 | $2.88 | $2.78 | 41,534 | 07-03-2024 |
$2.8233 | $2.84 | $2.8233 | $2.85 | $2.81 | 100,639 | 07-02-2024 |
$2.914 | $2.87 | $2.914 | $2.94 | $2.84 | 52,762 | 07-01-2024 |
$2.89 | $2.93 | $2.89 | $2.93 | $2.89 | 145,923 | 06-28-2024 |
$2.952 | $2.93 | $2.952 | $2.96 | $2.91 | 66,488 | 06-27-2024 |
$3.06 | $3.05 | $3.06 | $3.06 | $3.03 | 39,321 | 06-26-2024 |
$2.955 | $3.01 | $2.955 | $3.01 | $2.95 | 113,149 | 06-25-2024 |
$3.01 | $3.01 | $3.01 | $3.04 | $3.01 | 79,961 | 06-24-2024 |
$2.92 | $2.9227 | $2.92 | $2.94 | $2.917 | 54,418 | 06-21-2024 |
$2.9 | $2.88 | $2.9 | $2.9344 | $2.88 | 98,927 | 06-20-2024 |
$2.97 | $3.05 | $2.97 | $3.05 | $2.95 | 95,154 | 06-19-2024 |
$2.97 | $3.05 | $2.97 | $3.05 | $2.95 | 95,154 | 06-18-2024 |
$3 | $2.95 | $3 | $3.03 | $2.95 | 42,218 | 06-17-2024 |
$2.94 | $2.94 | $2.94 | $2.94 | $2.93 | 53,241 | 06-14-2024 |
$3.08 | $3.19 | $3.08 | $3.19 | $3.04 | 76,840 | 06-13-2024 |
$3.16 | $3.15 | $3.16 | $3.23 | $3.1001 | 481,715 | 06-12-2024 |
$2.75 | $2.78 | $2.75 | $2.78 | $2.72 | 93,033 | 06-11-2024 |
$2.85 | $2.81 | $2.85 | $2.85 | $2.81 | 15,515 | 06-10-2024 |
$2.8129 | $2.82 | $2.8129 | $2.8502 | $2.8129 | 63,059 | 06-07-2024 |
$2.9143 | $2.88 | $2.9143 | $2.93 | $2.88 | 119,277 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Wuxi Biologics Cayman Inc ADR Company Name:
WXXWY Stock Symbol:
OTCMKTS Market:
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale PR Newswire By leveraging WuXiUP TM , WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing ...
WuXi Biologics Receives AAA MSCI ESG Rating PR Newswire SHANGHAI , Nov. 7, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has received an AAA rating ...
WuXi Biologics Launches New High-Productivity Bioprocessing Platform WuXiUI™ for Cost-Effective Commercial Manufacturing and Desirable Product Quality PR Newswire WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibilit...